The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 19, 2000
Filed:
Jun. 17, 1999
Applicant:
Inventors:
Bjorn Olof Classon, Stockholm, SE;
Bengt Bertil Samuelsson, Onsala, SE;
Ingemar Sven-Anders Kvarnstrom, Linkoping, SE;
Lars Goran Svansson, Linkoping, SE;
Stefan Carl Svensson, Linkoping, SE;
Assignee:
Medivir AB, Huddinge, SE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07H / ; C07H / ; C07H / ; C07H / ; A61K / ;
U.S. Cl.
CPC ...
536-41 ; 514 45 ; 514 46 ; 514 47 ; 514 48 ; 514 49 ; 514 50 ; 514 51 ; 536 2623 ; 536 2626 ; 536 267 ; 536 268 ; 536 276 ; 536 278 ; 536 2781 ; 536 285 ; 536 2851 ; 536 2852 ; 536 2853 ; 536 2854 ; 536 2855 ; 544264 ; 544265 ; 544242 ; 544298 ; 544309 ; 544322 ;
Abstract
##STR1## Novel antiviral compounds of formulae (1A) and (1B), wherein X and R.sub.1 -R.sub.4 are as stated in claim 1 in the form of an .alpha.- or .beta.-anomer or a mixture thereof, and pharmaceutically acceptable salts thereof, are disclosed, as well as a new method for preparation thereof. Said compounds can be used for treatment of infections caused by viruses requiring reverse transcriptase for replication, such as HIV and hepatitis B virus.